• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障P-糖蛋白功能随衰老在特定脑区下降:在进行性神经退行性变中的可能作用。

Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.

作者信息

Bartels Anna L, Kortekaas Rudie, Bart Joost, Willemsen Antoon T M, de Klerk Onno L, de Vries Jeroen J, van Oostrom Joost C H, Leenders Klaus L

机构信息

Department of Neurology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

出版信息

Neurobiol Aging. 2009 Nov;30(11):1818-24. doi: 10.1016/j.neurobiolaging.2008.02.002. Epub 2008 Mar 20.

DOI:10.1016/j.neurobiolaging.2008.02.002
PMID:18358568
Abstract

Cerebrovascular P-glycoprotein (P-gp) acts at the blood-brain barrier (BBB) as an active cell membrane efflux pump for several endogenous and exogenous compounds. Age-associated decline in P-gp function could facilitate the accumulation of toxic substances in the brain, thus increasing the risk of neurodegenerative pathology with aging. We hypothesised a regionally reduced BBB P-gp function in older healthy subjects. We studied cerebrovascular P-gp function using [(11)C]-verapamil positron emission tomography (PET) in seventeen healthy volunteers with age 18-86. Logan analysis was used to calculate the distribution volume (DV) of [(11)C]-verapamil in the brain. Statistical Parametric Mapping was used to study specific regional differences between the older compared with the younger adults. Older subjects showed significantly decreased P-gp function in internal capsule and corona radiata white matter and in orbitofrontal regions. Decreased BBB P-gp function in those regions could thus explain part of the vulnerability of the aging brain to white matter degeneration. Moreover, decreased BBB P-gp function with aging could be a mechanism by which age acts as the main risk factor for the development of neurodegenerative disease.

摘要

脑血管P-糖蛋白(P-gp)在血脑屏障(BBB)处作为多种内源性和外源性化合物的活性细胞膜外排泵发挥作用。P-gp功能随年龄增长而下降可能会促进有毒物质在大脑中的积累,从而增加衰老过程中神经退行性病变的风险。我们假设在健康的老年受试者中,血脑屏障P-gp功能存在区域性降低。我们使用[(11)C]-维拉帕米正电子发射断层扫描(PET)对17名年龄在18-86岁的健康志愿者的脑血管P-gp功能进行了研究。采用Logan分析法计算[(11)C]-维拉帕米在大脑中的分布容积(DV)。使用统计参数映射法研究老年受试者与年轻受试者之间的特定区域差异。老年受试者在内囊、放射冠白质和眶额区域的P-gp功能显著降低。这些区域血脑屏障P-gp功能的降低可能解释了衰老大脑对白质变性易感性的部分原因。此外,随着年龄增长血脑屏障P-gp功能降低可能是年龄成为神经退行性疾病发展主要危险因素的一种机制。

相似文献

1
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.血脑屏障P-糖蛋白功能随衰老在特定脑区下降:在进行性神经退行性变中的可能作用。
Neurobiol Aging. 2009 Nov;30(11):1818-24. doi: 10.1016/j.neurobiolaging.2008.02.002. Epub 2008 Mar 20.
2
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.使用(R)-[(11)C]维拉帕米和正电子发射断层扫描测量年龄对血脑屏障中功能性P-糖蛋白的影响。
Clin Pharmacol Ther. 2006 Jun;79(6):540-8. doi: 10.1016/j.clpt.2006.02.004.
3
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier.局部脑区 P-糖蛋白功能在重度抑郁症中的增加:以 [11C]维拉帕米作为血脑屏障 P-糖蛋白功能探针的 PET 研究。
Int J Neuropsychopharmacol. 2009 Aug;12(7):895-904. doi: 10.1017/S1461145709009894. Epub 2009 Feb 19.
4
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function.慢性精神分裂症患者血脑屏障中 P-糖蛋白功能的区域性增加:以 [(11)C]维拉帕米作为 P-糖蛋白功能探针的 PET 研究。
Psychiatry Res. 2010 Aug 30;183(2):151-6. doi: 10.1016/j.pscychresns.2010.05.002.
5
Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil.利用11C-维拉帕米评估多药耐药基因1(MDR1)基因多态性在血脑屏障处的体内P-糖蛋白功能。
J Nucl Med. 2006 Sep;47(9):1427-33.
6
Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease.血脑屏障P-糖蛋白功能在早期帕金森病中未受损。
Parkinsonism Relat Disord. 2008 Aug;14(6):505-8. doi: 10.1016/j.parkreldis.2007.11.007. Epub 2008 Mar 5.
7
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.利用正电子发射断层扫描成像技术检测人类血脑屏障处P-糖蛋白的转运活性。
Clin Pharmacol Ther. 2005 Jun;77(6):503-14. doi: 10.1016/j.clpt.2005.01.022.
8
Blood-brain barrier P-glycoprotein function in Alzheimer's disease.阿尔茨海默病中的血脑屏障 P-糖蛋白功能。
Brain. 2012 Jan;135(Pt 1):181-9. doi: 10.1093/brain/awr298. Epub 2011 Nov 26.
9
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.帕金森病、进行性核上性麻痹和多系统萎缩进展过程中血脑屏障P-糖蛋白功能降低。
J Neural Transm (Vienna). 2008 Jul;115(7):1001-9. doi: 10.1007/s00702-008-0030-y. Epub 2008 Feb 12.
10
P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations.人类衰老和阿尔茨海默病中P-糖蛋白表达与淀粉样蛋白积累:初步观察
Neurobiol Aging. 2015 Sep;36(9):2475-82. doi: 10.1016/j.neurobiolaging.2015.05.020. Epub 2015 Jun 6.

引用本文的文献

1
Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier.血脑屏障处P-糖蛋白功能性别差异的探索性研究
Clin Transl Sci. 2025 Apr;18(4):e70196. doi: 10.1111/cts.70196.
2
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.在实验系统中增加淀粉样蛋白-β脑外排的方法。
J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.
3
Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches.通过调节ABC转运蛋白表达增强脑内β-淀粉样蛋白清除:实验方法综述
Front Aging Neurosci. 2024 May 30;16:1368200. doi: 10.3389/fnagi.2024.1368200. eCollection 2024.
4
Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System.ABC 转运蛋白在中枢神经系统胶质细胞中的新兴作用:健康与疾病。
Cells. 2024 Apr 24;13(9):740. doi: 10.3390/cells13090740.
5
Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays.通过调节肠道微生物群、昼夜节律及其相互作用来靶向血脑屏障,以延缓衰老相关的神经疾病。
Acta Pharm Sin B. 2023 Dec;13(12):4667-4687. doi: 10.1016/j.apsb.2023.08.009. Epub 2023 Aug 14.
6
Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy.ABCB1、CYP2C19和CYP2C9基因变异与青少年肌阵挛性癫痫的关联
Neurol Sci. 2024 Apr;45(4):1635-1643. doi: 10.1007/s10072-023-07124-w. Epub 2023 Oct 25.
7
Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.抗 tau 免疫疗法对脑疟疾实验模型中反应性小胶质细胞增生、脑内皮病变和认知功能的影响。
J Neurochem. 2023 Nov;167(3):441-460. doi: 10.1111/jnc.15972. Epub 2023 Oct 9.
8
[C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier.[C] 甲氧氯普胺是一种敏感的示踪剂,可测量血脑屏障中 P 糖蛋白功能的适度降低。
J Cereb Blood Flow Metab. 2024 Jan;44(1):142-152. doi: 10.1177/0271678X231202336. Epub 2023 Sep 20.
9
Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein.生成并鉴定 ABCB4 基因敲除斑马鱼模型,该基因编码人类多药外排转运蛋白 P-糖蛋白的同源物。
Hum Genomics. 2023 Sep 6;17(1):84. doi: 10.1186/s40246-023-00530-3.
10
Biological agents and the aging brain: glial inflammation and neurotoxic signaling.生物制剂与衰老大脑:神经胶质炎症和神经毒性信号传导
Front Aging. 2023 Aug 15;4:1244149. doi: 10.3389/fragi.2023.1244149. eCollection 2023.